Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001096906-14-000521
Filing Date
2014-04-23
Accepted
2014-04-23 10:02:18
Documents
6
Period of Report
2014-04-22
Effectiveness Date
2014-04-23

Document Format Files

Seq Description Document Type Size
1 AOXING PHARMACEUTICAL COMPANY, INC. SCHEDULE 14A aoxingdef14a.htm DEF 14A 299622
2 logo1.jpg GRAPHIC 7126
3 logo2.jpg GRAPHIC 1271
4 logo3.jpg GRAPHIC 1318
5 logo4.jpg GRAPHIC 1401
6 logo5.jpg GRAPHIC 1488
  Complete submission text file 0001096906-14-000521.txt   318958
Mailing Address 444 WASHINGTON BLVD SUITE 3338 JERSEY CITY NJ 07310
Business Address 444 WASHINGTON BLVD SUITE 3338 JERSEY CITY NJ 07310 646-367-1747
AOXING PHARMACEUTICAL COMPANY, INC. (Filer) CIK: 0001060426 (see all company filings)

EIN.: 650636168 | State of Incorp.: FL | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 001-32674 | Film No.: 14777714
SIC: 2834 Pharmaceutical Preparations